Submission Details
| 510(k) Number | K220929 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2022 |
| Decision Date | October 31, 2022 |
| Days to Decision | 214 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
K220929 is an FDA 510(k) clearance for the Excelsior, a System, Image Management, Ophthalmic (Class II — Special Controls, product code NFJ), submitted by Merit Cro, Inc. (Madison, US). The FDA issued a Cleared decision on October 31, 2022, 214 days after receiving the submission on March 31, 2022. This device falls under the Ophthalmic review panel. Regulated under 21 CFR 892.2050.
| 510(k) Number | K220929 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2022 |
| Decision Date | October 31, 2022 |
| Days to Decision | 214 days |
| Submission Type | Traditional |
| Review Panel | Ophthalmic (OP) |
| Summary | Summary PDF |
| Product Code | NFJ — System, Image Management, Ophthalmic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.2050 |